View in EDS

Toward precision prognosis: Predicting recurrence-free survival in high-grade serous ovarian cancer patients using multi-time point clinical and computed tomography radiomics data.

Saved in:
Bibliographic Details
Title: Toward precision prognosis: Predicting recurrence-free survival in high-grade serous ovarian cancer patients using multi-time point clinical and computed tomography radiomics data.
Authors: Roller L; Department of Radiology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Radiology, Brigham and Women's Hospital, Boston, MA, United States of America., Zhou N; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, United States of America., Atre I; Department of Radiology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Radiology, Brigham and Women's Hospital, Boston, MA, United States of America., Xiong N; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, United States of America., Li J; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, United States of America., Cheng SC; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, United States of America., Liu N; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America., Lacad D; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America., Adjei M; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America., Matulonis UA; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Medicine, Harvard Medical School, Boston, MA, United States of America., Konstantinopoulos PA; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Medicine, Harvard Medical School, Boston, MA, United States of America., Liu JF; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Medicine, Harvard Medical School, Boston, MA, United States of America., Tayob N; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Medicine, Harvard Medical School, Boston, MA, United States of America., Stover EH; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Medicine, Harvard Medical School, Boston, MA, United States of America. Electronic address: elizabeth_stover@dfci.harvard.edu., Shinagare AB; Department of Radiology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Radiology, Brigham and Women's Hospital, Boston, MA, United States of America.
Source: Gynecologic oncology [Gynecol Oncol] 2026 Jul 02; Vol. 211, pp. 98-107. Date of Electronic Publication: 2026 Jul 02.
Publication Type: Journal Article
Journal Info: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42391853
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Toward precision prognosis: Predicting recurrence-free survival in high-grade serous ovarian cancer patients using multi-time point clinical and computed tomography radiomics data.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Roller+L%22">Roller L</searchLink>; Department of Radiology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Radiology, Brigham and Women's Hospital, Boston, MA, United States of America.<br /><searchLink fieldCode="AU" term="%22Zhou+N%22">Zhou N</searchLink>; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, United States of America.<br /><searchLink fieldCode="AU" term="%22Atre+I%22">Atre I</searchLink>; Department of Radiology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Radiology, Brigham and Women's Hospital, Boston, MA, United States of America.<br /><searchLink fieldCode="AU" term="%22Xiong+N%22">Xiong N</searchLink>; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, United States of America.<br /><searchLink fieldCode="AU" term="%22Li+J%22">Li J</searchLink>; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, United States of America.<br /><searchLink fieldCode="AU" term="%22Cheng+SC%22">Cheng SC</searchLink>; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, United States of America.<br /><searchLink fieldCode="AU" term="%22Liu+N%22">Liu N</searchLink>; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.<br /><searchLink fieldCode="AU" term="%22Lacad+D%22">Lacad D</searchLink>; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.<br /><searchLink fieldCode="AU" term="%22Adjei+M%22">Adjei M</searchLink>; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.<br /><searchLink fieldCode="AU" term="%22Matulonis+UA%22">Matulonis UA</searchLink>; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Medicine, Harvard Medical School, Boston, MA, United States of America.<br /><searchLink fieldCode="AU" term="%22Konstantinopoulos+PA%22">Konstantinopoulos PA</searchLink>; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Medicine, Harvard Medical School, Boston, MA, United States of America.<br /><searchLink fieldCode="AU" term="%22Liu+JF%22">Liu JF</searchLink>; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Medicine, Harvard Medical School, Boston, MA, United States of America.<br /><searchLink fieldCode="AU" term="%22Tayob+N%22">Tayob N</searchLink>; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Medicine, Harvard Medical School, Boston, MA, United States of America.<br /><searchLink fieldCode="AU" term="%22Stover+EH%22">Stover EH</searchLink>; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Medicine, Harvard Medical School, Boston, MA, United States of America. Electronic address: elizabeth_stover@dfci.harvard.edu.<br /><searchLink fieldCode="AU" term="%22Shinagare+AB%22">Shinagare AB</searchLink>; Department of Radiology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Radiology, Brigham and Women's Hospital, Boston, MA, United States of America.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220365304%22">Gynecologic oncology</searchLink> [Gynecol Oncol] 2026 Jul 02; Vol. 211, pp. 98-107. <i>Date of Electronic Publication: </i>2026 Jul 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Academic+Press%22">Academic Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0365304 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1095-6859 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200908258%22">00908258 </searchLink><i>NLM ISO Abbreviation: </i>Gynecol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42391853
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ygyno.2026.06.007
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 98
    Titles:
      – TitleFull: Toward precision prognosis: Predicting recurrence-free survival in high-grade serous ovarian cancer patients using multi-time point clinical and computed tomography radiomics data.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Roller L
      – PersonEntity:
          Name:
            NameFull: Zhou N
      – PersonEntity:
          Name:
            NameFull: Atre I
      – PersonEntity:
          Name:
            NameFull: Xiong N
      – PersonEntity:
          Name:
            NameFull: Li J
      – PersonEntity:
          Name:
            NameFull: Cheng SC
      – PersonEntity:
          Name:
            NameFull: Liu N
      – PersonEntity:
          Name:
            NameFull: Lacad D
      – PersonEntity:
          Name:
            NameFull: Adjei M
      – PersonEntity:
          Name:
            NameFull: Matulonis UA
      – PersonEntity:
          Name:
            NameFull: Konstantinopoulos PA
      – PersonEntity:
          Name:
            NameFull: Liu JF
      – PersonEntity:
          Name:
            NameFull: Tayob N
      – PersonEntity:
          Name:
            NameFull: Stover EH
      – PersonEntity:
          Name:
            NameFull: Shinagare AB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 07
              Text: 2026 Jul 02
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1095-6859
          Numbering:
            – Type: volume
              Value: 211
          Titles:
            – TitleFull: Gynecologic oncology
              Type: main
ResultId 1